136
Views
3
CrossRef citations to date
0
Altmetric
Original

External Quality Assessment of HbA1c for Point of Care Testing

, &
Pages 201-208 | Received 30 Jun 2005, Accepted 08 Aug 2005, Published online: 12 Jul 2009

References

  • Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. (2003) Preva-lence of obesity, diabetes, and obesity-related health risk factors,. JAMA 289: 76–9.
  • Wild S, Roglic G, Green A, Sicree R, King H. 2004;Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–53.
  • The Diabetes Control and Complications Trial Research Group. (1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–86.
  • UK Prospective Diabetes Study (UKPDS) Group. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–53.
  • Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald .TM, Parrott M. (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes melli-tus. Chin Chem 48: 436–72.
  • American Diabetes Association. (2000) Type 2 diabetes in children and adolescents. Diabetes Care. 23: 381–9.
  • American Diabetes Association. (2000) Implications of the Diabetes Control and Complications Trial. Diabetes Care 23 Suppl 1: S24–6.
  • DiabetesControl and Complications Research Group. (1995) The relationship of glycemic expo-sure (HbAlc) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44: 968–83.
  • Gudbjornsdottir S, Cederholm J, Nilsson PM, Eliasson B. (2003) Steering Committee of the Swedish National Diabetes Register. The National Diabetes Register in Sweden: an implementa-tion of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26: 1270–6.
  • Arnqvist H, Wallensteen M, Jeppson JO. (1997) Standards for long-term measures of blood sugar are established. Läkartidningen 94: 4789–90.
  • Bunn HF, Hancy DN, Kamin S, Gabbay KH, Gallop PM. (1976) The biosynthesis of human hemoglobin Al c: slow glycosylation of hemoglobin in-vivo. J Chin Invest 57: 1652–1659.
  • Bunn HF. (1981) Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med 70: 325–30.
  • Stevens VJ, Vlassara H, Abati A, Cerami A. (1977) Nonenzymatic glycosylation of hemoglobin. J Biol Chem 252: 2998–3002.
  • Jovanovic L, Peterson CM. The clinical utility of glycosylated hemoglobin. (1981) Am J Med 70: 331–8.
  • Nathan DM, Singer DE, Hurxthal K, Goodson JD. (1984) The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310: 341–6.
  • Goldstein DE, Little RR, Lorenz RA, Malone II, Nathan D, Peterson CM. (1995) Tests of glyce-mia in diabetes. Diabetes Care 18: 896–909.
  • Virtue MA, Fume JK, Nuttall FQ, Levitt MD. (2004) Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27: 931–5.
  • Marshall SM, Barth JR. (2000) Standardization of HbAie measurements - a consensus statement. Diabet Med 17: 5–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.